Acadia Healthcare Co Raises FY2026 Adj EPS Guidance from $1.30-$1.55 to $1.35-$1.60 vs $1.49 Est; Affirms FY2026 Sales Guidance of $3.370B-$3.450B vs $3.413B Est

Benzinga Newsdesk www.benzinga.com Positive 87.0%

Neg 0% Neu 0% Pos 87%

Acadia Healthcare Co (NASDAQ:ACHC) raises FY2026 Adj EPS guidance from $1.30-$1.55 to $1.35-$1.60 vs $1.49 analyst estimate. Affirms FY2026 sales outlook from $3.370 billion-$3.450 billion to $3.370 billion-$3.450 billion vs $3.413 billion estimate.